| 000 | 01321cam a2200277 i 4500 | ||
|---|---|---|---|
| 008 | 800724s1980 dcu 000 0 eng | ||
| 020 | _a0844733938 (pbk.) | ||
| 040 |
_aDLC _cDLC |
||
| 050 | 0 | 0 |
_aRC961.5 _b.B43 |
| 082 | 0 | 0 |
_a362.1'0913 _bBEH |
| 100 | 1 | _aBehrman, Jack N. | |
| 245 | 1 | 0 |
_aTropical Diseases: _bResponses of pharmaceutical companies/ |
| 260 |
_aWashington, D.C.: _bAmerican Enterprise Institute for Public Policy Research, _cc1980. |
||
| 300 | _a74 p.:ill, | ||
| 440 | 0 | _aAEI studies ; 288 | |
| 504 | _aIncludes bibliographical footnotes. | ||
| 520 | _aThis book examines what the pharmaceutical companies have done in the past to combat the six most prevalent tropical diseases and what they are doing today, both within their own laboratories and in conjunction with health agencies in developing countries. The Brazilian program was examined at firsthand by the author, and the case study is based on interviews with officials of the government, observation of program activities in the field, and a review of documents provided by Brazilian officials. | ||
| 590 | _ane 22/05/2018 | ||
| 591 | _aLoans | ||
| 650 | 0 | _aTropical medicine | |
| 650 | 0 | _aPharmaceutical policy | |
| 650 | 0 | _aMedical policy | |
| 650 | 0 | _aSchistosomiasis- Brazil. | |
| 942 |
_2ddc _cBOOK |
||
| 949 | _a362.1'0913 BEH | ||
| 999 |
_c8768 _d8768 |
||